STAT

JANUARY 30, 2024

In response to concerns over multimillion-dollar price tags for new gene therapies for sickle cell disease, the U.S. government on Tuesday announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments. million and $3.1 million and $3.1

133

133

STAT

JANUARY 31, 2024

In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. government announced a long-awaited “access model” designed to blunt the cost that state Medicaid programs would pay for these curative treatments , STAT says. Two million and $3.1 million and $3.1

93

93

STAT

AUGUST 2, 2023

Medicare and Medicaid patients will make up 92% of the market for the drug, called Leqembi. Besides the $26,500 annual price tag, treatment could cost U.S. The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S.

Insurance Coverage 82

Insurance Coverage Insurance 82

The Checkup by Singlecare

DECEMBER 8, 2023

If there’s a drug you need to take, but you can’t swing the steep price tag, ask your pharmacist to check SingleCare’s prices. RELATED: Can I use SingleCare if I have Medicaid? These customers did just that to save big. RELATED: How can I save on my prescription?

Insurance 105

Insurance Customer Service Dosage 105

The Checkup by Singlecare

AUGUST 31, 2023

Medicaid may or may not cover a Mounjaro prescription. With a monthly price tag of $1,580, Mounjaro is no exception. Enroll in Medicaid If you qualify for Medicaid , there’s still a chance that your state doesn’t cover Mounjaro. Start by visiting your state’s Medicaid website for eligibility information.

Insurance 98

Insurance Compounding Insurance Coverage Labelling 98

pharmaphorum

OCTOBER 21, 2021

Aduhelm is currently under review by the Center for Medicare and Medicaid Services (CMS), which isn’t due to deliver recommendations on reimbursement until next year – which Vounatsos said was delaying treatment for patients who might benefit from the drug.

Insurance 120

Insurance FDA 120

pharmaphorum

DECEMBER 17, 2021

Aduhelm (aducanumab) was approved by the FDA in June, but has been held back by a glacial rollout as clinicians have questioned the data on which the decision to clear the drug was based, plus a $56,000 per year price tag, which has in turn led to pushback by payers.

FDA 52

FDA 52